Selective non-zinc binding MMP-2 inhibitors: Novel benzamide Ilomastat analogs with anti-tumor metastasis
Authors:
- 1 May 2016
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 26 (9) , 2174-2178
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81373276)
- Shanghai Municipal Committee of Science and Technology (14XD1400300, 13431900101)
- National Science and Technology Major Project of China (2013ZX09J13103-02C)
This publication has 28 references indexed in Scilit:
- Molecular Design of a Highly Selective and Strong Protein Inhibitor against Matrix Metalloproteinase-2 (MMP-2)Journal of Biological Chemistry, 2013
- Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9European Journal of Medicinal Chemistry, 2012
- Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivityBioorganic & Medicinal Chemistry, 2008
- Novel Aminophenyl Benzamide-Type Histone Deacetylase Inhibitors with Enhanced Potency and SelectivityJournal of Medicinal Chemistry, 2007
- Simultaneous presence of unsaturation and long alkyl chain at of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studiesBioorganic & Medicinal Chemistry, 2007
- Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapyNature Reviews Cancer, 2006
- Expression of Matrix Metalloproteinase-9 in Head and Neck Squamous Cell CarcinomaClinical Cancer Research, 2004
- Crystal Structure of Human MMP9 in Complex with a Reverse Hydroxamate InhibitorJournal of Molecular Biology, 2002
- Matrix Metalloproteinase Inhibitors: A Structure−Activity StudyJournal of Medicinal Chemistry, 1998
- Remodeling MMPIsNature Biotechnology, 1995